1. Home
  2. List
Reference Patent

Reference - List

  • 20 Hits
  • Search Condition : Filter (MeSH = HSP90 Heat-Shock Proteins / antagonists & inhibitors*)
Species Resource Title
Human and Animal Cells OCUB-M(RCB0881) Targeted inhibition of Hsp90 by ganetespib is effective across a broad spectrum of breast cancer subtypes.
Human and Animal Cells HFL-I(RCB0521) TAS-116, a Novel Hsp90 Inhibitor, Selectively Enhances Radiosensitivity of Human Cancer Cells to X-rays and Carbon Ion Radiation.
Human and Animal Cells PC-9(RCB4455) Inhibition of heat shock protein 90 destabilizes receptor tyrosine kinase ROR1 in lung adenocarcinoma.
Human and Animal Cells TKKK(RCB1907) , HuCCT1(RCB1960) , TGBC24TKB(RCB1196) Heat Shock Protein 90 Is a Potential Therapeutic Target in Cholangiocarcinoma.
Human and Animal Cells NB1RGB(RCB0222) Preferential sensitization of tumor cells to radiation by heat shock protein 90 inhibitor geldanamycin.
Drosophila Little effect of HSP90 inhibition on the quantitative wing traits variation in Drosophila melanogaster.
Human and Animal Cells C2C12(RCB0987) Pharmacological targeting of HSP90 with 17-AAG induces apoptosis of myogenic cells through activation of the intrinsic pathway.
Human and Animal Cells G-415(RCB2640) , TGBC1TKB(RCB1129) , TGBC2TKB(RCB1130) , TGBC24TKB(RCB1196) Small molecule inhibitor screening identifified HSP90 inhibitor 17-AAG as potential therapeutic agent for gallbladder cancer.
Human and Animal Cells SQ-5(RCB0110) The purine scaffold Hsp90 inhibitor PU-H71 sensitizes cancer cells to heavy ion radiation by inhibiting DNA repair by homologous recombination and non-homologous end joining.
Human and Animal Cells EBC-1(RCB1965) Enhanced antitumor activity of erlotinib in combination with the Hsp90 inhibitor CH5164840 against non-small-cell lung cancer.
Human and Animal Cells 293(RCB1637) Cytotoxic activity to acute myeloid leukemia cells by Antp-TPR hybrid peptide targeting Hsp90.
Human and Animal Cells SQ-5(RCB0110) Inhibition of homologous recombination repair in irradiated tumor cells pretreated with Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin.
Human and Animal Cells SQ-5(RCB0110) Geldanamycin, an inhibitor of Hsp90, sensitizes human tumour cells to radiation.
Human and Animal Cells 32D(RCB1145) Selective apoptosis of tandemly duplicated FLT3-transformed leukemia cells by Hsp90 inhibitors.
Human and Animal Cells 293T(RCB2202) Designed hybrid TPR peptide targeting Hsp90 as a novel anticancer agent.
Human and Animal Cells 32D(RCB1145) Selective KIT inhibitor KI-328 and HSP90 inhibitor show different potency against the type of KIT mutations recurrently identified in acute myeloid leukemia.
Human and Animal Cells HFL-III(RCB0523) , SQ-5(RCB0110) The combination of Hsp90 inhibitor 17AAG and heavy-ion irradiation provides effective tumor control in human lung cancer cells.
Human and Animal Cells SK-N-SH(RCB0426) Inhibition of heat shock protein 90 attenuates adenylate cyclase sensitization after chronic morphine treatment.
Human and Animal Cells MKN45(RCB1001) Antitumor activity of SNX-2112, a synthetic heat shock protein-90 inhibitor, in MET-amplified tumor cells with or without resistance to selective MET Inhibition.
DNA material pHSP90 (RDB01127) Hsp90 is a direct target of the anti-allergic drugs disodium cromoglycate and amlexanox.